Does EFALIZUMAB Cause Cardiomyopathy? 7 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Cardiomyopathy have been filed in association with EFALIZUMAB. This represents 3.0% of all adverse event reports for EFALIZUMAB.
7
Reports of Cardiomyopathy with EFALIZUMAB
3.0%
of all EFALIZUMAB reports
1
Deaths
6
Hospitalizations
How Dangerous Is Cardiomyopathy From EFALIZUMAB?
Of the 7 reports, 1 (14.3%) resulted in death, 6 (85.7%) required hospitalization.
Is Cardiomyopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EFALIZUMAB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does EFALIZUMAB Cause?
Death (56)
Psoriasis (55)
Pruritus (35)
Erythema (28)
Drug ineffective (26)
Pain (25)
Decreased appetite (24)
Hypersensitivity (24)
Vomiting (24)
Nausea (23)
What Other Drugs Cause Cardiomyopathy?
DOXORUBICIN (820)
CYCLOPHOSPHAMIDE (581)
SACUBITRIL\VALSARTAN (444)
CLOZAPINE (404)
PREDNISONE (379)
RITUXIMAB (379)
ROSIGLITAZONE (374)
VINCRISTINE (326)
TRASTUZUMAB (292)
HYDROXYCHLOROQUINE (231)
Which EFALIZUMAB Alternatives Have Lower Cardiomyopathy Risk?
EFALIZUMAB vs EFANESOCTOCOG ALFA
EFALIZUMAB vs EFAVIRENZ
EFALIZUMAB vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL
EFALIZUMAB vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL
EFALIZUMAB vs EFFEXOR